236 related articles for article (PubMed ID: 24192212)
1. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A.
Wang C; Huang Q; Wang C; Zhu X; Duan Y; Yuan S; Bai X
Toxicol Appl Pharmacol; 2013 Nov; 272(3):895-904. PubMed ID: 23933165
[TBL] [Abstract][Full Text] [Related]
3. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
7. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
Sun CY; Pei CQ; Zang BX; Wang L; Jin M
Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats].
Wang XF; Jin M; Tong J; Wu W; Li JR; Zang BX
Yao Xue Xue Bao; 2010 Jul; 45(7):940-4. PubMed ID: 20931796
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
Wang J; Zhang Q; Mei X; Zhang X
Pharm Biol; 2014 Jan; 52(1):31-5. PubMed ID: 24033225
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
13. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
14. The effects of hydroxysafflor yellow A on blood pressure and cardiac function.
Nie PH; Zhang L; Zhang WH; Rong WF; Zhi JM
J Ethnopharmacol; 2012 Feb; 139(3):746-50. PubMed ID: 22197825
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A attenuates lymphostatic encephalopathy-induced brain injury in rats.
Pan Y; Zheng DY; Liu SM; Meng Y; Xu HY; Zhang Q; Gong J; Xia ZL; Chen LB; Li HY
Phytother Res; 2012 Oct; 26(10):1500-6. PubMed ID: 22318911
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms.
Zhu HB; Zhang L; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
J Asian Nat Prod Res; 2005 Aug; 7(4):607-13. PubMed ID: 16087635
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling.
Song Y; Long L; Zhang N; Liu Y
Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury.
Wu Y; Wang L; Jin M; Zang BX
Biol Pharm Bull; 2012; 35(4):515-22. PubMed ID: 22466555
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action.
Tian J; Li G; Liu Z; Fu F
Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
